Is The EU's New Directive On Clinical Trials Moving In The Wrong Direction?

It's a cliché that we live in a world increasingly awash with digital data. Even though it all comes down to 1s and 0s, not all data is equally important or valuable. Data about clinical trials, for example, is literally a matter of life and death, since it is used to determine whether new drugs should be approved and how they should be used. That gives clinical data a critical role in the approval process: results that support the use of a new drug can lead to big profits, while negative results can mean years of expensive research and development have to be discarded. 

On Techdirt.